Data as of May 24
| +0.70 / +1.17%|
The 14 analysts offering 12-month price forecasts for Salix Pharmaceuticals Ltd have a median target of 60.00, with a high estimate of 67.50 and a low estimate of 48.00. The median estimate represents a -0.65% decrease from the last price of 60.39.
The current consensus among 18 polled investment analysts is to Buy stock in Salix Pharmaceuticals Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.